Surgical Innovations GroupLSE:SUN OCF Margin % is 14.81% as of Dec. 2025, which is 184% above its 10-year median of 5.22. The stock has 2 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Surgical Innovations Group ranks worse than 53.06% on this metric.
The historical rank and industry rank for Surgical Innovations Group's OCF Margin % or its related term are showing as below:
LSE:SUN'
s OCF Margin % Range Over the Past 10 Years
Min: -4.74 Med: 5.22 Max: 46.72
Current: 4.9
During the past 13 years, the highest OCF Margin % of Surgical Innovations Group was 46.72%. The lowest was -4.74%. And the median was 5.22%.
LSE:SUN's OCF Margin % is ranked worse than 53.06% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 5.84
vs LSE:SUN: 4.90
Surgical Innovations Group OCF Margin % Related Terms
Surgical Innovations Group OCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Surgical Innovations Group's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgical Innovations Group OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Surgical Innovations Group's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Surgical Innovations Group's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surgical Innovations Group (LSE:SUN) has a OCF Margin % of 14.81% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Surgical Innovations Group and its competitors. This is 184% above median its historical median of 5.22. According to the industry distribution chart, Surgical Innovations Group ranks #433 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 53.1%.
Is Surgical Innovations Group's OCF Margin % too high?
Surgical Innovations Group's current OCF Margin % of 14.81% is 184% above median its 10-year median of 5.22. The Medical Devices & Instruments industry median OCF Margin % is 5.84. Surgical Innovations Group's value of 14.81% is 153.6% above this industry median. Based on the distribution chart, Surgical Innovations Group ranks #433 out of 816 companies in the Medical Devices & Instruments industry, which is below the industry midpoint.
How does Surgical Innovations Group's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Surgical Innovations Group ranks #433 out of 816 companies for OCF Margin %. This places Surgical Innovations Group in the lower half of its industry. The industry median OCF Margin % is 5.84. Surgical Innovations Group's value of 14.81% is 153.6% above this benchmark. While the company's 10-year median is 5.22 vs. the industry median of 5.84, Surgical Innovations Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.84, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Surgical Innovations Group's current OCF Margin % of 14.81% is 153.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Surgical Innovations Group and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surgical Innovations Group's current OCF Margin % is 14.81%, which is 184% above median its own 10-year median of 5.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgical Innovations Group stock overvalued right now?
Based on GuruFocus' analysis, Surgical Innovations Group (LSE:SUN) is currently considered Possible Value Trap. The stock's GF Value™ is £0.01, compared to a current price of £0.00 — trading 52.5% below its estimated fair value. The current OCF Margin % is 14.81%, which is 184% above median its 10-year median of 5.22 and 153.6% above the Medical Devices & Instruments industry median of 5.84. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Surgical Innovations Group (LSE:SUN), the current OCF Margin % is 14.81% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Surgical Innovations Group PLC is involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery (SI Brand), along with its label products through original equipment manufacturer (OEM) relationships, including precision engineering markets (PE). The Company's operating segments are SI Brand, OEM, and Distribution. The majority of its revenue is generated from the SI Brand segment, which is involved in the research, development, manufacture, and distribution of SI-branded minimally invasive devices. Geographically, the group derives a majority of its revenue from the United Kingdom, followed by Europe, the United States, the Asia-Pacific region, and the Rest of the world.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:SUN has been successfully added to your 